OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Small molecular CD73 inhibitors: Recent progress and future perspectives
Gong-hui Ge, Qiu-yin Wang, Zhen-hao Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116028-116028
Closed Access | Times Cited: 8
Gong-hui Ge, Qiu-yin Wang, Zhen-hao Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116028-116028
Closed Access | Times Cited: 8
Showing 8 citing articles:
Betulonic acid: A review on its sources, biological activities, and molecular mechanisms
Shengying Lou, Chunyan Dai, Yuhua Wu, et al.
European Journal of Pharmacology (2025), pp. 177518-177518
Closed Access
Shengying Lou, Chunyan Dai, Yuhua Wu, et al.
European Journal of Pharmacology (2025), pp. 177518-177518
Closed Access
Development of CD73 Inhibitors in Tumor Immunotherapy and Opportunities in Imaging and Combination Therapy
Chunyang Bi, Jimmy S. Patel, Steven H. Liang
Journal of Medicinal Chemistry (2025)
Open Access
Chunyang Bi, Jimmy S. Patel, Steven H. Liang
Journal of Medicinal Chemistry (2025)
Open Access
Acyclic purine and pyrimidine nucleotide analogs as ecto-5’-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Břehová, et al.
European Journal of Medicinal Chemistry (2025), pp. 117653-117653
Open Access
Stephanie Federico, Christian Renn, Petra Břehová, et al.
European Journal of Medicinal Chemistry (2025), pp. 117653-117653
Open Access
Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 775-776
Open Access | Times Cited: 2
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 775-776
Open Access | Times Cited: 2
CD73 promotes non–small cell lung cancer metastasis by regulating Axl signaling independent of GAS6
Jianjie Zhu, Wenwen Du, Yuanyuan Zeng, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 43
Open Access | Times Cited: 1
Jianjie Zhu, Wenwen Du, Yuanyuan Zeng, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 43
Open Access | Times Cited: 1
Novel CD73 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 571-572
Closed Access
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 571-572
Closed Access
Design, synthesis and structure-activity relationship of malonic acid non-nucleoside derivatives as potent CD73 inhibitors
Cunjian Shi, Jingqi Dai, Longfeng Chang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129946-129946
Closed Access
Cunjian Shi, Jingqi Dai, Longfeng Chang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129946-129946
Closed Access
Novel Bicyclic Heterocyclic Compounds as CD73 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 16, Iss. 1, pp. 10-11
Closed Access
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 16, Iss. 1, pp. 10-11
Closed Access
Third‐Generation CD73 Inhibitors Based on a 4,6‐Disubstituted‐2‐thiopyridine Scaffold
Félix Grosjean, Maria Shaldaeva, Emeline Cros‐Perrial, et al.
ChemMedChem (2024)
Open Access
Félix Grosjean, Maria Shaldaeva, Emeline Cros‐Perrial, et al.
ChemMedChem (2024)
Open Access
